Literature DB >> 3603674

Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function.

J English, A Evan, D C Houghton, W M Bennett.   

Abstract

Dose-related cyclosporine-induced renal dysfunction is the most frequent adverse effect noted with this exciting immunosuppressive drug. To investigate pathogenetic factors involved, we studied renal tubular function and afferent arteriolar morphology during severe experimental cyclosporine-induced reduction in glomerular filtration rate. Pair-fed male rats were given cyclosporine 50 mg/kg or olive oil vehicle alone by gavage for periods of 3-14 days. Glomerular filtration rate declined progressively, reaching a nadir of 0.18 +/- .05 ml/min/100 g vs. .86 +/- .03 ml/min/100 g in controls at 14 days (P less than 0.001). Despite the severe reduction in glomerular filtration rate there was no difference in fractional sodium excretion, fractional lithium excretion, enzymuria, or in vitro renal cortical slice uptake of tetraethylammonium in cyclosporine and vehicle-treated animals. Light microscopy showed vacuolar changes without evidence of tubular necrosis at 7 and 14 days in cyclosporine-treated rats. Progressive decline in the diameter of the afferent arteriole was noted by scanning electron microscopy. By day 14 the lumenal diameter of afferent arterioles from cyclosporine-treated animals was 8.9 +/- 0.4 micron vs. 13.5 +/- 0.4 micron in controls (P less than 0.05). We conclude that afferent arteriolar vasoconstriction rather than direct tubular injury is a major pathogenetic factor in experimental cyclosporine nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3603674     DOI: 10.1097/00007890-198707000-00027

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  28 in total

1.  Deletion of mineralocorticoid receptors in smooth muscle cells blunts renal vascular resistance following acute cyclosporine administration.

Authors:  Cristian A Amador; Jean-Philippe Bertocchio; Gwennan Andre-Gregoire; Sandrine Placier; Jean-Paul Duong Van Huyen; Soumaya El Moghrabi; Stefan Berger; David G Warnock; Christos Chatziantoniou; Iris Z Jaffe; Philippe Rieu; Frederic Jaisser
Journal:  Kidney Int       Date:  2016-02       Impact factor: 10.612

Review 2.  Use of calcium antagonists in renal patients: therapeutic benefit or medical malpractice?

Authors:  Douglas A Nigbor; Julia B Lewis
Journal:  Curr Hypertens Rep       Date:  2003-10       Impact factor: 5.369

3.  Conversion of cardiac and liver transplant recipients from HPLC and FPIA (polyclonal) to an FPIA (monoclonal) technique for measurement of blood cyclosporin A.

Authors:  J H McBride; S Kim; D O Rodgerson; A Reyes
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

Review 4.  Isolated glomeruli and cultured mesangial cells as in vitro models to study immunosuppressive agents.

Authors:  M Potier; B L'Azou; J Cambar
Journal:  Cell Biol Toxicol       Date:  1996-12       Impact factor: 6.691

Review 5.  Current status of renal transplantation.

Authors:  M G Suranyi; B M Hall
Journal:  West J Med       Date:  1990-06

6.  Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells.

Authors:  T E Bunchman; C A Brookshire
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

7.  Annexin A1 protein attenuates cyclosporine-induced renal hemodynamics changes and macrophage infiltration in rats.

Authors:  Leandro Pires Araujo; Renata Ramos Truzzi; Gloria Elisa Florido Mendes; Marcus Alexandre Mendes Luz; Emmanuel A Burdmann; Sonia Maria Oliani
Journal:  Inflamm Res       Date:  2011-11-19       Impact factor: 4.575

Review 8.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

9.  Cyclosporin therapy in vivo attenuates the response to vasodilators in the isolated perfused kidney of the rabbit.

Authors:  H S Cairns; L D Fairbanks; J Westwick; G H Neild
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

Review 10.  The Kidney in Pediatric Liver Disease.

Authors:  Robyn Greenfield Matloff; Ronen Arnon
Journal:  Curr Gastroenterol Rep       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.